Verastem, Inc. — Investor Relations & Filings
Verastem, Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for cancer patients. The company concentrates on targeting the RAS/MAPK signaling pathway, which is associated with numerous aggressive and recurrent cancers. Its clinical program utilizes novel small molecule inhibitors and combination therapies. Verastem has achieved a significant milestone with the FDA approval of its combination therapy, the first treatment specifically for patients with recurrent low-grade serous ovarian cancer (LGSOC) harboring a KRAS mutation. The company's mission is to address urgent medical needs by developing innovative treatments for cancers driven by the RAS/MAPK pathway.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 4 - Verastem, Inc. (0001526119) (Issuer) | 2026-03-23 | English | |
| 8-K - VERASTEM, INC. (0001526119) (Filer) | 2026-03-04 | English | |
| 10-K - VERASTEM, INC. (0001526119) (Filer) | 2026-03-04 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 33016560 | 4 - Verastem, Inc. (0001526119) (Issuer) | 2026-03-23 | English | ||
| 32893357 | 8-K - VERASTEM, INC. (0001526119) (Filer) | 2026-03-04 | English | ||
| 32893358 | 10-K - VERASTEM, INC. (0001526119) (Filer) | 2026-03-04 | English | ||
| 30355410 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30355407 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30355402 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30355401 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30355427 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 32893356 | 4 - VERASTEM, INC. (0001526119) (Filer) | 2026-02-05 | English | ||
| 30355479 | 8-K Filing | 2026-02-04 | English | ||
| 30355462 | 4 Filing | 2026-01-23 | English | ||
| 30355403 | 4 Filing | 2026-01-23 | English | ||
| 30355399 | 4 Filing | 2026-01-14 | English | ||
| 30355396 | 4 Filing | 2026-01-14 | English | ||
| 12467337 | FORM 8-K | 2026-01-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
Verastem, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32713/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32713 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32713 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32713 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32713}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Verastem, Inc. (id: 32713)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.